The Orissa Minerals Development Company Limited
The Orissa Minerals Development Company Limited (ORISSAMINE.BO) Stock Competitors & Peer Comparison
See (ORISSAMINE.BO) competitors and their performances in Stock Market.
Peer Comparison Table: Industrial Materials Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| ORISSAMINE.BO | ₹3,486.45 | +5.28% | 20.3B | -52.72 | -₹64.32 | N/A |
| VEDL.BO | ₹669.80 | +3.72% | 2.5T | 18.09 | ₹36.03 | +3.53% |
| VEDL.NS | ₹669.65 | +3.70% | 2.5T | 18.08 | ₹36.03 | +3.53% |
| HINDZINC.NS | ₹517.70 | +6.16% | 2.1T | 17.79 | ₹27.94 | +5.83% |
| HINDZINC.BO | ₹517.35 | +6.08% | 2.1T | 17.80 | ₹27.93 | +5.83% |
| MOIL.NS | ₹289.20 | +1.38% | 58.9B | 20.27 | ₹14.29 | +2.40% |
| MOIL.BO | ₹288.85 | +1.28% | 58.9B | 20.26 | ₹14.29 | +2.40% |
| ASHAPURMIN.NS | ₹489.55 | +2.23% | 46.7B | 12.37 | ₹39.52 | +0.20% |
| ASHAPURMIN.BO | ₹488.35 | +1.29% | 46.6B | 12.35 | ₹39.52 | +0.20% |
| ORISSAMINE.NS | ₹3,489.50 | +6.02% | 20.3B | -75.86 | -₹44.69 | N/A |
Stock Comparison
ORISSAMINE.BO vs VEDL.BO Comparison March 2026
ORISSAMINE.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORISSAMINE.BO stands at 20.3B. In comparison, VEDL.BO has a market cap of 2.5T. Regarding current trading prices, ORISSAMINE.BO is priced at ₹3,486.45, while VEDL.BO trades at ₹669.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORISSAMINE.BO currently has a P/E ratio of -52.72, whereas VEDL.BO's P/E ratio is 18.09. In terms of profitability, ORISSAMINE.BO's ROE is +0.64%, compared to VEDL.BO's ROE of +0.31%. Regarding short-term risk, ORISSAMINE.BO is more volatile compared to VEDL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ORISSAMINE.BO.Check VEDL.BO's competition here
ORISSAMINE.BO vs VEDL.NS Comparison March 2026
ORISSAMINE.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORISSAMINE.BO stands at 20.3B. In comparison, VEDL.NS has a market cap of 2.5T. Regarding current trading prices, ORISSAMINE.BO is priced at ₹3,486.45, while VEDL.NS trades at ₹669.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORISSAMINE.BO currently has a P/E ratio of -52.72, whereas VEDL.NS's P/E ratio is 18.08. In terms of profitability, ORISSAMINE.BO's ROE is +0.64%, compared to VEDL.NS's ROE of +0.31%. Regarding short-term risk, ORISSAMINE.BO is more volatile compared to VEDL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ORISSAMINE.BO.Check VEDL.NS's competition here
ORISSAMINE.BO vs HINDZINC.NS Comparison March 2026
ORISSAMINE.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORISSAMINE.BO stands at 20.3B. In comparison, HINDZINC.NS has a market cap of 2.1T. Regarding current trading prices, ORISSAMINE.BO is priced at ₹3,486.45, while HINDZINC.NS trades at ₹517.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORISSAMINE.BO currently has a P/E ratio of -52.72, whereas HINDZINC.NS's P/E ratio is 17.79. In terms of profitability, ORISSAMINE.BO's ROE is +0.64%, compared to HINDZINC.NS's ROE of +0.98%. Regarding short-term risk, ORISSAMINE.BO is more volatile compared to HINDZINC.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ORISSAMINE.BO.Check HINDZINC.NS's competition here
ORISSAMINE.BO vs HINDZINC.BO Comparison March 2026
ORISSAMINE.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORISSAMINE.BO stands at 20.3B. In comparison, HINDZINC.BO has a market cap of 2.1T. Regarding current trading prices, ORISSAMINE.BO is priced at ₹3,486.45, while HINDZINC.BO trades at ₹517.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORISSAMINE.BO currently has a P/E ratio of -52.72, whereas HINDZINC.BO's P/E ratio is 17.80. In terms of profitability, ORISSAMINE.BO's ROE is +0.64%, compared to HINDZINC.BO's ROE of +0.98%. Regarding short-term risk, ORISSAMINE.BO is more volatile compared to HINDZINC.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ORISSAMINE.BO.Check HINDZINC.BO's competition here
ORISSAMINE.BO vs MOIL.NS Comparison March 2026
ORISSAMINE.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORISSAMINE.BO stands at 20.3B. In comparison, MOIL.NS has a market cap of 58.9B. Regarding current trading prices, ORISSAMINE.BO is priced at ₹3,486.45, while MOIL.NS trades at ₹289.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORISSAMINE.BO currently has a P/E ratio of -52.72, whereas MOIL.NS's P/E ratio is 20.27. In terms of profitability, ORISSAMINE.BO's ROE is +0.64%, compared to MOIL.NS's ROE of +0.11%. Regarding short-term risk, ORISSAMINE.BO is more volatile compared to MOIL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ORISSAMINE.BO.Check MOIL.NS's competition here
ORISSAMINE.BO vs MOIL.BO Comparison March 2026
ORISSAMINE.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORISSAMINE.BO stands at 20.3B. In comparison, MOIL.BO has a market cap of 58.9B. Regarding current trading prices, ORISSAMINE.BO is priced at ₹3,486.45, while MOIL.BO trades at ₹288.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORISSAMINE.BO currently has a P/E ratio of -52.72, whereas MOIL.BO's P/E ratio is 20.26. In terms of profitability, ORISSAMINE.BO's ROE is +0.64%, compared to MOIL.BO's ROE of +0.11%. Regarding short-term risk, ORISSAMINE.BO is less volatile compared to MOIL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ORISSAMINE.BO.Check MOIL.BO's competition here
ORISSAMINE.BO vs ASHAPURMIN.NS Comparison March 2026
ORISSAMINE.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORISSAMINE.BO stands at 20.3B. In comparison, ASHAPURMIN.NS has a market cap of 46.7B. Regarding current trading prices, ORISSAMINE.BO is priced at ₹3,486.45, while ASHAPURMIN.NS trades at ₹489.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORISSAMINE.BO currently has a P/E ratio of -52.72, whereas ASHAPURMIN.NS's P/E ratio is 12.37. In terms of profitability, ORISSAMINE.BO's ROE is +0.64%, compared to ASHAPURMIN.NS's ROE of +0.31%. Regarding short-term risk, ORISSAMINE.BO is less volatile compared to ASHAPURMIN.NS. This indicates potentially lower risk in terms of short-term price fluctuations for ORISSAMINE.BO.Check ASHAPURMIN.NS's competition here
ORISSAMINE.BO vs ASHAPURMIN.BO Comparison March 2026
ORISSAMINE.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORISSAMINE.BO stands at 20.3B. In comparison, ASHAPURMIN.BO has a market cap of 46.6B. Regarding current trading prices, ORISSAMINE.BO is priced at ₹3,486.45, while ASHAPURMIN.BO trades at ₹488.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORISSAMINE.BO currently has a P/E ratio of -52.72, whereas ASHAPURMIN.BO's P/E ratio is 12.35. In terms of profitability, ORISSAMINE.BO's ROE is +0.64%, compared to ASHAPURMIN.BO's ROE of +0.31%. Regarding short-term risk, ORISSAMINE.BO is less volatile compared to ASHAPURMIN.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ORISSAMINE.BO.Check ASHAPURMIN.BO's competition here
ORISSAMINE.BO vs ORISSAMINE.NS Comparison March 2026
ORISSAMINE.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORISSAMINE.BO stands at 20.3B. In comparison, ORISSAMINE.NS has a market cap of 20.3B. Regarding current trading prices, ORISSAMINE.BO is priced at ₹3,486.45, while ORISSAMINE.NS trades at ₹3,489.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORISSAMINE.BO currently has a P/E ratio of -52.72, whereas ORISSAMINE.NS's P/E ratio is -75.86. In terms of profitability, ORISSAMINE.BO's ROE is +0.64%, compared to ORISSAMINE.NS's ROE of +0.64%. Regarding short-term risk, ORISSAMINE.BO is less volatile compared to ORISSAMINE.NS. This indicates potentially lower risk in terms of short-term price fluctuations for ORISSAMINE.BO.Check ORISSAMINE.NS's competition here
ORISSAMINE.BO vs JGCHEM.NS Comparison March 2026
ORISSAMINE.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORISSAMINE.BO stands at 20.3B. In comparison, JGCHEM.NS has a market cap of 12.8B. Regarding current trading prices, ORISSAMINE.BO is priced at ₹3,486.45, while JGCHEM.NS trades at ₹334.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORISSAMINE.BO currently has a P/E ratio of -52.72, whereas JGCHEM.NS's P/E ratio is 20.29. In terms of profitability, ORISSAMINE.BO's ROE is +0.64%, compared to JGCHEM.NS's ROE of +0.13%. Regarding short-term risk, ORISSAMINE.BO is less volatile compared to JGCHEM.NS. This indicates potentially lower risk in terms of short-term price fluctuations for ORISSAMINE.BO.Check JGCHEM.NS's competition here
ORISSAMINE.BO vs SCFL.BO Comparison March 2026
ORISSAMINE.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORISSAMINE.BO stands at 20.3B. In comparison, SCFL.BO has a market cap of 5.9B. Regarding current trading prices, ORISSAMINE.BO is priced at ₹3,486.45, while SCFL.BO trades at ₹26.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORISSAMINE.BO currently has a P/E ratio of -52.72, whereas SCFL.BO's P/E ratio is N/A. In terms of profitability, ORISSAMINE.BO's ROE is +0.64%, compared to SCFL.BO's ROE of -0.05%. Regarding short-term risk, ORISSAMINE.BO is less volatile compared to SCFL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ORISSAMINE.BO.Check SCFL.BO's competition here
ORISSAMINE.BO vs 20MICRONS.BO Comparison March 2026
ORISSAMINE.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORISSAMINE.BO stands at 20.3B. In comparison, 20MICRONS.BO has a market cap of 5.2B. Regarding current trading prices, ORISSAMINE.BO is priced at ₹3,486.45, while 20MICRONS.BO trades at ₹150.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORISSAMINE.BO currently has a P/E ratio of -52.72, whereas 20MICRONS.BO's P/E ratio is 8.08. In terms of profitability, ORISSAMINE.BO's ROE is +0.64%, compared to 20MICRONS.BO's ROE of +0.15%. Regarding short-term risk, ORISSAMINE.BO is less volatile compared to 20MICRONS.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ORISSAMINE.BO.Check 20MICRONS.BO's competition here
ORISSAMINE.BO vs 20MICRONS.NS Comparison March 2026
ORISSAMINE.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORISSAMINE.BO stands at 20.3B. In comparison, 20MICRONS.NS has a market cap of 5.2B. Regarding current trading prices, ORISSAMINE.BO is priced at ₹3,486.45, while 20MICRONS.NS trades at ₹151.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORISSAMINE.BO currently has a P/E ratio of -52.72, whereas 20MICRONS.NS's P/E ratio is 8.06. In terms of profitability, ORISSAMINE.BO's ROE is +0.64%, compared to 20MICRONS.NS's ROE of +0.15%. Regarding short-term risk, ORISSAMINE.BO is less volatile compared to 20MICRONS.NS. This indicates potentially lower risk in terms of short-term price fluctuations for ORISSAMINE.BO.Check 20MICRONS.NS's competition here
ORISSAMINE.BO vs EMAMIPAP.NS Comparison March 2026
ORISSAMINE.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORISSAMINE.BO stands at 20.3B. In comparison, EMAMIPAP.NS has a market cap of 3.9B. Regarding current trading prices, ORISSAMINE.BO is priced at ₹3,486.45, while EMAMIPAP.NS trades at ₹64.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORISSAMINE.BO currently has a P/E ratio of -52.72, whereas EMAMIPAP.NS's P/E ratio is 13.48. In terms of profitability, ORISSAMINE.BO's ROE is +0.64%, compared to EMAMIPAP.NS's ROE of +0.05%. Regarding short-term risk, ORISSAMINE.BO is less volatile compared to EMAMIPAP.NS. This indicates potentially lower risk in terms of short-term price fluctuations for ORISSAMINE.BO.Check EMAMIPAP.NS's competition here
ORISSAMINE.BO vs SICAGEN.NS Comparison March 2026
ORISSAMINE.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORISSAMINE.BO stands at 20.3B. In comparison, SICAGEN.NS has a market cap of 973.5M. Regarding current trading prices, ORISSAMINE.BO is priced at ₹3,486.45, while SICAGEN.NS trades at ₹24.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORISSAMINE.BO currently has a P/E ratio of -52.72, whereas SICAGEN.NS's P/E ratio is -164.00. In terms of profitability, ORISSAMINE.BO's ROE is +0.64%, compared to SICAGEN.NS's ROE of +0.04%. Regarding short-term risk, ORISSAMINE.BO is less volatile compared to SICAGEN.NS. This indicates potentially lower risk in terms of short-term price fluctuations for ORISSAMINE.BO.Check SICAGEN.NS's competition here
ORISSAMINE.BO vs RAJMET.NS Comparison March 2026
ORISSAMINE.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORISSAMINE.BO stands at 20.3B. In comparison, RAJMET.NS has a market cap of 857.1M. Regarding current trading prices, ORISSAMINE.BO is priced at ₹3,486.45, while RAJMET.NS trades at ₹3.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORISSAMINE.BO currently has a P/E ratio of -52.72, whereas RAJMET.NS's P/E ratio is -38.75. In terms of profitability, ORISSAMINE.BO's ROE is +0.64%, compared to RAJMET.NS's ROE of -0.02%. Regarding short-term risk, ORISSAMINE.BO is less volatile compared to RAJMET.NS. This indicates potentially lower risk in terms of short-term price fluctuations for ORISSAMINE.BO.Check RAJMET.NS's competition here
ORISSAMINE.BO vs PATSPINLTD.NS Comparison March 2026
ORISSAMINE.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORISSAMINE.BO stands at 20.3B. In comparison, PATSPINLTD.NS has a market cap of 436M. Regarding current trading prices, ORISSAMINE.BO is priced at ₹3,486.45, while PATSPINLTD.NS trades at ₹14.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORISSAMINE.BO currently has a P/E ratio of -52.72, whereas PATSPINLTD.NS's P/E ratio is -3.18. In terms of profitability, ORISSAMINE.BO's ROE is +0.64%, compared to PATSPINLTD.NS's ROE of +0.33%. Regarding short-term risk, ORISSAMINE.BO is less volatile compared to PATSPINLTD.NS. This indicates potentially lower risk in terms of short-term price fluctuations for ORISSAMINE.BO.Check PATSPINLTD.NS's competition here
ORISSAMINE.BO vs IMPEXFERRO.BO Comparison March 2026
ORISSAMINE.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORISSAMINE.BO stands at 20.3B. In comparison, IMPEXFERRO.BO has a market cap of 129.3M. Regarding current trading prices, ORISSAMINE.BO is priced at ₹3,486.45, while IMPEXFERRO.BO trades at ₹1.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORISSAMINE.BO currently has a P/E ratio of -52.72, whereas IMPEXFERRO.BO's P/E ratio is -1.77. In terms of profitability, ORISSAMINE.BO's ROE is +0.64%, compared to IMPEXFERRO.BO's ROE of +0.02%. Regarding short-term risk, ORISSAMINE.BO is less volatile compared to IMPEXFERRO.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ORISSAMINE.BO.Check IMPEXFERRO.BO's competition here
ORISSAMINE.BO vs IMPEXFERRO.NS Comparison March 2026
ORISSAMINE.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORISSAMINE.BO stands at 20.3B. In comparison, IMPEXFERRO.NS has a market cap of 125.7M. Regarding current trading prices, ORISSAMINE.BO is priced at ₹3,486.45, while IMPEXFERRO.NS trades at ₹1.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORISSAMINE.BO currently has a P/E ratio of -52.72, whereas IMPEXFERRO.NS's P/E ratio is -1.74. In terms of profitability, ORISSAMINE.BO's ROE is +0.64%, compared to IMPEXFERRO.NS's ROE of +0.02%. Regarding short-term risk, ORISSAMINE.BO is less volatile compared to IMPEXFERRO.NS. This indicates potentially lower risk in terms of short-term price fluctuations for ORISSAMINE.BO.Check IMPEXFERRO.NS's competition here
ORISSAMINE.BO vs ARENTERP.BO Comparison March 2026
ORISSAMINE.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORISSAMINE.BO stands at 20.3B. In comparison, ARENTERP.BO has a market cap of 115.5M. Regarding current trading prices, ORISSAMINE.BO is priced at ₹3,486.45, while ARENTERP.BO trades at ₹37.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORISSAMINE.BO currently has a P/E ratio of -52.72, whereas ARENTERP.BO's P/E ratio is -530.86. In terms of profitability, ORISSAMINE.BO's ROE is +0.64%, compared to ARENTERP.BO's ROE of -0.00%. Regarding short-term risk, ORISSAMINE.BO is less volatile compared to ARENTERP.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ORISSAMINE.BO.Check ARENTERP.BO's competition here
ORISSAMINE.BO vs ARENTERP.NS Comparison March 2026
ORISSAMINE.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORISSAMINE.BO stands at 20.3B. In comparison, ARENTERP.NS has a market cap of 114.3M. Regarding current trading prices, ORISSAMINE.BO is priced at ₹3,486.45, while ARENTERP.NS trades at ₹36.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORISSAMINE.BO currently has a P/E ratio of -52.72, whereas ARENTERP.NS's P/E ratio is -525.29. In terms of profitability, ORISSAMINE.BO's ROE is +0.64%, compared to ARENTERP.NS's ROE of -0.00%. Regarding short-term risk, ORISSAMINE.BO is less volatile compared to ARENTERP.NS. This indicates potentially lower risk in terms of short-term price fluctuations for ORISSAMINE.BO.Check ARENTERP.NS's competition here
ORISSAMINE.BO vs PRECISION.BO Comparison March 2026
ORISSAMINE.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORISSAMINE.BO stands at 20.3B. In comparison, PRECISION.BO has a market cap of 48.3M. Regarding current trading prices, ORISSAMINE.BO is priced at ₹3,486.45, while PRECISION.BO trades at ₹54.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORISSAMINE.BO currently has a P/E ratio of -52.72, whereas PRECISION.BO's P/E ratio is -495.41. In terms of profitability, ORISSAMINE.BO's ROE is +0.64%, compared to PRECISION.BO's ROE of +0.00%. Regarding short-term risk, ORISSAMINE.BO is less volatile compared to PRECISION.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ORISSAMINE.BO.Check PRECISION.BO's competition here
ORISSAMINE.BO vs METKORE.NS Comparison March 2026
ORISSAMINE.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORISSAMINE.BO stands at 20.3B. In comparison, METKORE.NS has a market cap of 47.2M. Regarding current trading prices, ORISSAMINE.BO is priced at ₹3,486.45, while METKORE.NS trades at ₹0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORISSAMINE.BO currently has a P/E ratio of -52.72, whereas METKORE.NS's P/E ratio is -0.40. In terms of profitability, ORISSAMINE.BO's ROE is +0.64%, compared to METKORE.NS's ROE of -1.25%. Regarding short-term risk, ORISSAMINE.BO is less volatile compared to METKORE.NS. This indicates potentially lower risk in terms of short-term price fluctuations for ORISSAMINE.BO.Check METKORE.NS's competition here
ORISSAMINE.BO vs SEZAL.NS Comparison March 2026
ORISSAMINE.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORISSAMINE.BO stands at 20.3B. In comparison, SEZAL.NS has a market cap of 0. Regarding current trading prices, ORISSAMINE.BO is priced at ₹3,486.45, while SEZAL.NS trades at ₹5.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORISSAMINE.BO currently has a P/E ratio of -52.72, whereas SEZAL.NS's P/E ratio is -0.00. In terms of profitability, ORISSAMINE.BO's ROE is +0.64%, compared to SEZAL.NS's ROE of +0.15%. Regarding short-term risk, ORISSAMINE.BO is more volatile compared to SEZAL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ORISSAMINE.BO.Check SEZAL.NS's competition here
ORISSAMINE.BO vs ORIENTREF.NS Comparison March 2026
ORISSAMINE.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORISSAMINE.BO stands at 20.3B. In comparison, ORIENTREF.NS has a market cap of 0. Regarding current trading prices, ORISSAMINE.BO is priced at ₹3,486.45, while ORIENTREF.NS trades at ₹324.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORISSAMINE.BO currently has a P/E ratio of -52.72, whereas ORIENTREF.NS's P/E ratio is 53.11. In terms of profitability, ORISSAMINE.BO's ROE is +0.64%, compared to ORIENTREF.NS's ROE of +0.22%. Regarding short-term risk, ORISSAMINE.BO is more volatile compared to ORIENTREF.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ORISSAMINE.BO.Check ORIENTREF.NS's competition here